Clinical Trials Directory

Trials / Completed

CompletedNCT02135237

Contingency Management for Alcohol Use Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
UConn Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) is a new technology designed to continuously monitor alcohol consumption 24 hours a day for 7 days per week. The purpose of this study is to evaluate the efficacy of CM in reducing alcohol use using SCRAMx. In total, 120 alcohol abusing or dependent patients initiating outpatient treatment at community-based clinics will be randomly assigned to one of two conditions: standard care, or standard care plus CM with reinforcement based on results of SCRAMx readings. Compared with standard care, it is expected that CM will result in fewer drinking days and longer durations of continuous non-drinking days.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPrize Contingency Management for Alcohol AbstinenceThe systematic reinforcement of desired behaviors and the withholding of reinforcement for undesired behaviors
BEHAVIORALStandard Care

Timeline

Start date
2014-01-01
Primary completion
2019-06-01
Completion
2019-06-01
First posted
2014-05-09
Last updated
2019-11-01

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02135237. Inclusion in this directory is not an endorsement.